KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Long-Term Investments (2016 - 2025)

Historic Long-Term Investments for Bristol Myers Squibb (BMY) over the last 16 years, with Q4 2025 value amounting to $396.0 million.

  • Bristol Myers Squibb's Long-Term Investments rose 2375.0% to $396.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $396.0 million, marking a year-over-year increase of 2375.0%. This contributed to the annual value of $396.0 million for FY2025, which is 2375.0% up from last year.
  • Bristol Myers Squibb's Long-Term Investments amounted to $396.0 million in Q4 2025, which was up 2375.0% from $406.0 million recorded in Q3 2025.
  • Bristol Myers Squibb's Long-Term Investments' 5-year high stood at $406.0 million during Q3 2025, with a 5-year trough of $46.0 million in Q3 2021.
  • In the last 4 years, Bristol Myers Squibb's Long-Term Investments had a median value of $345.0 million in 2025 and averaged $308.4 million.
  • Per our database at Business Quant, Bristol Myers Squibb's Long-Term Investments plummeted by 9070.71% in 2021 and then surged by 2530.86% in 2025.
  • Quarter analysis of 4 years shows Bristol Myers Squibb's Long-Term Investments stood at $46.0 million in 2021, then surged by 691.3% to $364.0 million in 2023, then fell by 12.09% to $320.0 million in 2024, then increased by 23.75% to $396.0 million in 2025.
  • Its Long-Term Investments stands at $396.0 million for Q4 2025, versus $406.0 million for Q3 2025 and $346.0 million for Q2 2025.